BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Oncology

Australia Approved New Therapy to Treat Advanced Small Cell Lung Cancer

Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more tha...

September 15, 2021 | News

Taiwan to provide smart access to personalized cancer care

Varian, a Siemens Healthineers company, announced today that China Medical University Hospital in Central Taiwan treated its first patient with E...

September 13, 2021 | News

China strengthen it's Proton Therapy System

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research...

September 13, 2021 | News

Merck to Present Latest Highlights From Oncology Portfolio at WCLC and ESMO 2021

Merck, a leading science and technology company, today announced research from Company-sponsored, investigator-sponsored, and collaborative studies —...

September 13, 2021 | News

Illumina Partners with Merck to advance cancer diagnostics and precision medicine.

Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop an...

September 08, 2021 | News

Dr. Reddy’s Lab to sell its rights to anti-cancer agent E7777

Under the terms of agreement, Dr. Reddy’s will receive $40 million upfront upon the closing of the transaction, followed by approval milestone paymen...

September 06, 2021 | News

Single Cell Discoveries joins consortium to build a single-cell cancer atlas to find therapy resistant tumor cells

This collaborative research program aims to provide the cancer research community with a new gold standard workflow for single-cell sequencing by developin...

September 02, 2021 | News

Merck’s KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has received two new ...

August 30, 2021 | News

Elekta to address Indonesia's cancer care gap with direct presence

Elekta (EKTA-B.ST) announced today that is has established permanent legal entity in Indonesia's capital, Jakarta in order to address t...

August 25, 2021 | News

Argon Announces the Commercial Launch of the SKATER™

The SKATER™ Mini-Loop is a drainage catheter placed through the skin using imaging guidance as a minimally invasive way to remove or drain an unwante...

August 23, 2021 | News

Technology Investments will Help Oncology Practices Succeed in Value-based Care

Community oncology practices are continuing to adapt to value-based reimbursement models as the Centers for Medicare and Medicaid Services (CMS) prepares t...

August 12, 2021 | News

VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody

The targets have been identified by Indivumed’s discovery solution platform nRavel®, only two months after its launch. The antibody development a...

August 10, 2021 | News

Australia Unite to Urgently Tackle 'Symptom Hesitancy' and Testing 'Rollercoaster

Growing concern among Australian cancer organisations that ongoing COVID-19 lockdowns, and delays in routine procedures are causing cancer 'symptom ...

August 10, 2021 | News

Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model

Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today announced the first public presentation of data from a preclinical study of PXS-5505...

August 06, 2021 | News

Stay Connected